KISSEI PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss
The total revenue of 4547 for the last quarter is 20.88 B JPY, and it's 18.21% higher compared to the previous quarter. The net income of Q3 23 is 2.66 B JPY.